
As the first patient to receive an experimental treatment that relied on the gene-editing technique CRISPR continues to do well 17 months later, more patients seem to be benefiting, too.
(Image credit: Victoria Gray )
News : NPR
1. NPR from Michael_Novakhov (25 sites)
1. Podcasts from Michael_Novakhov (17 sites)